Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien launches new contrast delivery system for CT

This article was originally published in Clinica

Executive Summary

Covidien has launched its contrast delivery system with radiofrequency identification (RFID) technology in the US. The system could reduce medical errors and increase efficiency in CT imaging, the Hamilton, Bermuda-based firm said. It combines Covidien's Ultraject prefilled contrast media syringes with its Optivantage DH power injector. The RFID technology captures, stores and transmits data between the syringe and the injector, which helps technicians ensure that each patient receives the correct dose of contrast medium. The US FDA granted 510(k) clearance for the system in May.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043167

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel